
台股指數近期持續走高,5日單日上漲1236.30點收於49712.04點創新高,但Dcard理財板討論顯示,仍有許多投資人持有個股如國巨、劍湖山、00988A等處於虧損狀態,甚至有人頻繁交易卻獲利微薄;同時也有網友透過持有0050 ETF累積獲利,凸顯市場分化與投資風險。
AI-generated summary
台股指數近期持續上揚,5日單日大漲1236.30點收於49712.04點創歷史新高,但市場參與者的投資體驗並不一致。
股市不斷創新高,但並非每位投資人都賺錢。(彭博資料照)
〔財經頻道/綜合報導〕台股近期一路走高,今(5)日上漲1236.30點,收49712.04點創新高,但即使如此,並不代表每位投資人都賺錢。一名網友近日在Dcard理財板以「都快五萬點了誰帳上還是虧?」為題發文,好奇詢問還有哪些投資人的帳面損益仍是負數,意外釣出不少套牢苦主分享持股與投資戰績。
留言區隨即湧入不少「慘烈」案例,有人直接點名「國巨1200」,也有人透露「劍湖山還-50%賣不掉」,另有不少人表示手中的00988A目前仍處於負報酬。此外,元太、牧德、旺宏、康寧等個股也被點名,顯示即使大盤持續走強,部分個股表現仍相當疲弱。
請繼續往下閱讀...
也有人曬出自己的持股績效,自嘲「虧得可慘了」,手中兩檔股票分別虧損17%及60%,即使台股已處於高檔,個人帳面績效仍與大盤形成明顯落差。
還有投資人分享,自己聽從朋友建議買進啟碁及精成科,卻剛好在7月大跌前的相對高點進場。如今台股指數已重新走強,手中的兩檔股票卻仍沒有跟上,不僅帳面虧損,也讓他陷入「捨不得停損」的兩難。
除了套牢個股,也有人感嘆頻繁交易未必能賺錢。一名網友透露,今年累計交易金額已達1600萬元,但最後獲利不到1萬元,忍不住自嘲「不知道在忙什麼」。
另一名網友則分享朋友的當沖經驗,投入約100萬元操作,單月交易金額甚至高達1億元,最後卻虧損20多萬元,最終選擇退出當沖。
不過,討論串中也有投資人交出亮眼成績。一名網友表示,目前持有2480股0050,帳面獲利約9.9萬元,並設定明年底累積至4000股的目標。
整串討論也再次呈現出台股創高背後的不同投資樣貌,有人靠著ETF跟上市場行情、順利累積獲利,也有人因選股、進場時機或頻繁交易,至今仍陷在虧損之中。但無論如何,提醒投資人,投資理財有風險,仍應衡量自身風險承受度,切勿盲目跟瘋追高。
一手掌握經濟脈動 點我訂閱自由財經Youtube頻道
AI outlook — possibilities, not facts
台股短期內可能維持震盪走高,但個股分化或將持續
Likely · Within weeks
部分套牢投資人可能在未來數月選擇停損或調整持倉
Possible · Within months

The Taiwan stock market index soared on Monday, led by TSMC, and closed at a new high of 49,712 points. Foreign investors bought more than 71.897 billion yuan. Among them, Wistron became the biggest winner of foreign investors, buying more than 24,800 shares, driving the stock price up 1.61% to close at 189.5 yuan.

Chief Executive Officer Toh Wing-tai recently stated that the 10,000-yuan universal payment will be distributed as soon as possible before the Lunar New Year. Deputy Finance Minister Chen Yongsheng said today that the payment will be expedited in accordance with the instructions of the Executive Yuan and will be distributed under the principle of not increasing debt and not crowding out social welfare and public construction budgets, and called on the Legislative Yuan to complete the budget review as soon as possible.

Taiwan Microsystems, a subsidiary of TLC-KY, signed an exclusive licensing agreement with Nippon Organ Pharmaceuticals, and Nippon Organ Pharmaceuticals obtained the development and commercialization rights of long-acting analgesic drug TLC599 in Japan. The total amount reached US$203 million, setting a record for the highest amount in the history of Taiwan-Japan biotechnology cooperation.

Mingjian Township in Nantou is facing a sharp decline in tea tea prices. County Councilor Song Huailin asked questions and asked to develop countermeasures. County Mayor Xu Shuhua said that she has sought subsidies from the Ministry of Agriculture and will coordinate procurement and expand diversified overseas channels through farmers' associations to protect the livelihood of tea farmers.

Japan's semiconductor global market share fell from more than 50% to less than 5%. Japanese media commented that the gap between Japan and Taiwan is not in funds, but in educational ideology and social structure. It is suggested that Japan should learn from Taiwan and cultivate highly skilled talents with "independence and self-esteem" to revive the industry.

British SMMT data shows that new car registrations in September 2026 will increase by 12% year-on-year. Chinese car brands have expanded rapidly, with their market share increasing to 12%. A Chinese model became the best-selling model in the UK in September, and demand for electric vehicles has also grown strongly.